Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lanolin

This article was originally published in The Rose Sheet

Executive Summary

Proposed duty increase on substances derived from wool, including lanolin, "would have a significant, deleterious effect on the U.S. cosmetics industry," CTFA asserts in comments to the U.S. Trade Representative. Lanolin, used in 25 cosmetics formulations, is included on USTR's tentative list of products subject to a 100% tariff if the European Union does not comply with the World Trade Organization's ruling on the EU's ban on U.S. hormone-treated beef ("The Rose Sheet" April 12, In Brief). A worldwide shortage of lanolin already exists, CTFA points out, adding that the price of the ingredient has increased 40%-50% in the past nine months. In addition, EU lanolin is preferred over other sources. The issue was further complicated by a May 3 Commission report, which found that the hormones used to treat U.S. beef are carcinogenic. The U.S. countered the findings, stating four decades of studies have proven the contrary
Advertisement

Related Content

USTR on lanolin
USTR on lanolin
Advertisement
UsernamePublicRestriction

Register

RS006642

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel